Observational studies of treatment effectiveness: worthwhile or worthless?

References

• PearceWRamanSTurnerARandomised trials in context: practical problems and social aspects of evidence-based medicine and policyTrials20151639426341114
   PubMed Web of Science ®Google Scholar
• GreenlandSMansourniaMALimitations of individual causal models, causal graphs, and ignorability assumptions, as illustrated by random confounding and design unfaithfulnessEur J Epidemiol201530101101111025687168
   PubMed Web of Science ®Google Scholar
• HernánMARobinsJMUsing big data to emulate a target trial when a randomized trial is not availableAm J Epidemiol2016183875876426994063
   PubMed Web of Science ®Google Scholar
• PocockSJElbourneDRRandomized trials or observational tribulations?N Engl J Med2000342251907190910861329
   PubMed Web of Science ®Google Scholar
• FreemantleNMarstonLWaltersKMaking inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational researchBMJ2013347f640924217206
   PubMed Web of Science ®Google Scholar
• BlackNWhy we need observational studies to evaluate the effectiveness of health careBMJ19963127040121512188634569
   PubMed Web of Science ®Google Scholar
• VelentgasPDreyerNNourjahPSmithSRTorchiaMMDeveloping a Protocol for Observational Comparative Effectiveness Research: A User’s GuideAHRQ Publication No 12(13)-EHC099Rockville, MDAgency for Healthcare Research and Quality2013 Available from: www.effectivehealthcare.ahrq.gov/Methods-OCER.cfmAccessed July 6, 2018
   Google Scholar
• PetersenIDouglasIWhitakerHSelf controlled case series methods: an alternative to standard epidemiological study designsBMJ2016354i451527618829
   PubMed Web of Science ®Google Scholar
• PearceNAnalysis of matched case-control studiesBMJ2016352i96926916049
   PubMed Web of Science ®Google Scholar
• HernánMACounterpoint: epidemiology to guide decision-making: moving away from practice-free researchAm J Epidemiol20151821083483926507306
   PubMed Web of Science ®Google Scholar
• RayWAEvaluating medication effects outside of clinical trials: new-user designsAm J Epidemiol2003158991592014585769
   PubMed Web of Science ®Google Scholar
• CauleyJASeeleyDGBrownerWSEstrogen replacement therapy and mortality among older women. The study of osteoporotic fracturesArch Intern Med199715719218121879342994
   PubMedGoogle Scholar
• VandenbrouckeJPearceNPoint: incident exposures, prevalent exposures, and causal inference: does limiting studies to persons who are followed from first exposure onward damage epidemiology?Am J Epidemiol20151821082683326507305
   PubMed Web of Science ®Google Scholar
• PittBZannadFRemmeWJThe effect of spironolactone on morbidity and mortality in patients with severe heart failureN Engl J Med19993411070971710471456
   PubMed Web of Science ®Google Scholar
• SmeethLDouglasIHallAJHubbardREvansSEffect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trialsBr J Clin Pharmacol20096719910919006546
   PubMed Web of Science ®Google Scholar
• FurbergCDPittBAre all angiotensin-converting enzyme inhibitors interchangeable?J Am Coll Cardiol20013751456146011300461
   PubMed Web of Science ®Google Scholar
• NørgaardMEhrensteinVVandenbrouckeJPConfounding in observational studies based on large health care databases: problems and potential solutions – a primer for the clinicianClin Epidemiol2017918519328405173
   PubMed Web of Science ®Google Scholar
• VanderweeleTJHernánMARobinsJMCausal directed acyclic graphs and the direction of unmeasured confounding biasEpidemiology200819572072818633331
   PubMed Web of Science ®Google Scholar
• GreenlandSPearlJRobinsJMCausal diagrams for epidemiologic researchEpidemiology199910137489888278
   PubMed Web of Science ®Google Scholar
• WilliamsonEMorleyRLucasACarpenterJPropensity scores: from naive enthusiasm to intuitive understandingStat Methods Med Res201221327329321262780
   PubMed Web of Science ®Google Scholar
• PatornoEGoldfineABSchneeweissSCardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort studyBMJ2018360k11929437648
   PubMed Web of Science ®Google Scholar
• ShahBRLaupacisAHuxJEAustinPCPropensity score methods gave similar results to traditional regression modeling in observational studies: a systematic reviewJ Clin Epidemiol200558655055915878468
   PubMed Web of Science ®Google Scholar
• SchneeweissSSensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeuticsPharmacoepidemiol Drug Saf200615529130316447304
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care ExcellenceNICE NG28: type 2 diabetes in adults: management Last updated May 2017 Available from: https://www.nice.org.uk/guidance/ng28/resources/type-2-diabetes-in-adults-management-1837338615493Accessed July 19, 2018
   Google Scholar
• BlakBTThompsonMDattaniHBourkeAGeneralisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality ratesInform Prim Care201119425125522828580
   PubMedGoogle Scholar
• SharmaMPetersenINazarethICotonSJAn algorithm for identification and classification of individuals with type 1 and type 2 diabetes mellitus in a large primary care databaseClin Epidemiol2016837338027785102
   PubMed Web of Science ®Google Scholar
• StrattonIMAdlerAINeilHAAssociation of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ2000321725840541210938048
   PubMed Web of Science ®Google Scholar
• SharmaMBeckleyNNazarethIPetersenIEffectiveness of sitagliptin compared to sulfonylureas for type 2 diabetes mellitus inadequately controlled on metformin: a systematic review and meta-analysisBMJ Open2017710e017260
   Web of Science ®Google Scholar
• PedersenABMikkelsenEMCronin-FentonDMissing data and multiple imputation in clinical epidemiological researchClin Epidemiol2017915716628352203
   PubMed Web of Science ®Google Scholar
• AhrénBJohnsonSLStewartMHARMONY 3 Study GroupHARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metforminDiabetes Care20143782141214824898304
   PubMed Web of Science ®Google Scholar
• ArechavaletaRSeckTChenYEfficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trialDiabetes Obes Metab201113216016821199268
   PubMed Web of Science ®Google Scholar
• SeckTNauckMShengDSitagliptin Study 024 GroupSafety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year studyInt J Clin Pract201064556257620456211
   PubMed Web of Science ®Google Scholar